Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

Memorial Sloan Kettering Cancer Center, New York

Columbia University Irving Medical Center, New York

Montefiore Medical Center, The Bronx

University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh

Thomas Jefferson University/Sidney Kimmel Cancer Center, Philadelphia

Sibley Memorial Hospital Johns Hopkins Medicine, Washington D.C.

The Center for Cancer and Blood Disorders, Bethesda

Johns Hopkins Bayview Medical Center, Baltimore

Inova Schar Cancer Institute, Fairfax

Next Ocology, Fairfax

UNC Hospitals - Lineberger Comprehensive Cancer Center, Chapel Hill

Durham VA Medical Center, Durham

Emory Winship Cancer Center, Atlanta

Mayo Clinic- Jacksonville, Jacksonville

Orlando Health Cancer Institute, Orlando

Miami Cancer Institute - Baptist Health South Florida, Miami

University of Alabama, Birmingham

Tennessee Oncology, Nashville

The West Clinic PLLC, dba West Cancer Center, Germantown

Ohio State Comprehensive Cancer Center, Columbus

Cleveland Clinic, Cleveland

Indiana University, Indianapolis

Mayo Clinic- Rochester, Rochester

Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago

Siteman Cancer Center, St Louis

University of Kansas Cancer Center, Fairway

Mary Crowley Cancer Research, Dallas

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas

The University of Texas MD Anderson Cancer Center, Houston

Rocky Mountain Cancer Center, Lone Tree

Banner MD Anderson Cancer Center, Gilbert

Cedars Sinai Medical Center, Los Angeles

Valkyrie Clinical Trials, Los Angeles

City of Hope Comprehensive Cancer Center (Duarte Campus), Duarte

City of Hope Orange County Lennar Foundation Cancer Center, Irvine

City of Hope Huntington Beach, Huntington Beach

UHP- University of Hawaii Cancer Center, Honolulu

Fred Hutchinson Cancer Center/University of Washington, Seattle

Dana-Farber Cancer Institute, Boston

Dartmouth Hitchcock Medical Center, Lebanon

Princess Margaret Cancer Center- University Health Network, Toronto